Royal Prima Past Earnings Performance

Past criteria checks 0/6

Royal Prima's earnings have been declining at an average annual rate of -24.4%, while the Healthcare industry saw earnings growing at 3.7% annually. Revenues have been growing at an average rate of 3.3% per year.

Key information

-24.4%

Earnings growth rate

-24.5%

EPS growth rate

Healthcare Industry Growth14.1%
Revenue growth rate3.3%
Return on equity-0.7%
Net Margin-2.2%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Royal Prima makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

IDX:PRIM Revenue, expenses and earnings (IDR Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 24297,892-6,58977,4450
30 Jun 24285,950-2,41574,0480
31 Mar 24275,63138371,3620
31 Dec 23265,337-2,74769,7360
30 Sep 23248,383-4,95868,0740
30 Jun 23230,455-2,70867,5800
31 Mar 23239,49710,48465,9210
31 Dec 22261,93321,58965,8750
30 Sep 22283,857-17,61463,3210
30 Jun 22464,06422,84972,2960
31 Mar 22583,21463,65274,1160
31 Dec 21599,96475,43469,8740
30 Sep 21619,090125,91260,2270
30 Jun 21460,98899,02446,9970
31 Mar 21311,04851,72439,3400
31 Dec 20260,59138,17037,4120
30 Sep 20205,05018,13531,8530
30 Jun 20178,1372,66331,7620
31 Mar 20181,0032,46433,2020
31 Dec 19174,2172,39732,3470
30 Sep 19176,0054,92342,3880
30 Jun 19187,58411,06140,6550
31 Mar 19195,13113,96837,6410
31 Dec 18204,79517,20538,4940
30 Sep 18196,4656,63629,2440
30 Jun 18193,47714,31326,5930
31 Mar 18186,00518,64224,5900
31 Dec 17177,59620,19920,6340
31 Dec 16137,92111,54514,5160
31 Dec 1572,7371,82710,3540
31 Dec 1416,652-2,3047,8710

Quality Earnings: PRIM is currently unprofitable.

Growing Profit Margin: PRIM is currently unprofitable.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: PRIM is unprofitable, and losses have increased over the past 5 years at a rate of 24.4% per year.

Accelerating Growth: Unable to compare PRIM's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: PRIM is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (2.7%).


Return on Equity

High ROE: PRIM has a negative Return on Equity (-0.69%), as it is currently unprofitable.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/04 20:23
End of Day Share Price 2025/01/03 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

PT Royal Prima Tbk is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution